RhumbLine Advisers’s Tvardi Therapeutics TVRD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $155K | Buy |
|
|||||
|
2025
Q2 | $79.6K | Buy |
|
|||||
|
2024
Q3 | – | Sell |
|
|||||
|
2024
Q2 | $7.91K | Sell |
|
|||||
|
2024
Q1 | $70K | Buy |
|
|||||
|
2023
Q4 | $54.8K | Sell |
|
|||||
|
2023
Q3 | $128K | Sell |
|
|||||
|
2023
Q2 | $217K | Sell |
|
|||||
|
2023
Q1 | $760K | Buy |
|
|||||
|
2022
Q4 | $1.57M | Buy |
|
|||||
|
2022
Q3 | $1.36M | Buy |
|
|||||
|
2022
Q2 | $1.25M | Buy |
|
|||||
|
2022
Q1 | $1.58M | Buy |
|
|||||
|
2021
Q4 | $1.58M | Sell |
|
|||||
|
2021
Q3 | $2.02M | Sell |
|
|||||
|
2021
Q2 | $2.12M | Buy |
|
|||||
|
2021
Q1 | $1.16M | Sell |
|
|||||
|
2020
Q4 | $863K | Buy |
|
|||||
|
2020
Q3 | $698K | Sell |
|
|||||
|
2020
Q2 | $1.08M | Buy |
|
|||||
|
2020
Q1 | $777K | Sell |
|
|||||
|
2019
Q4 | $986K | Buy |
|
|||||
|
2019
Q3 | $1.03M | Buy |
|
|||||
|
2019
Q2 | $1.1M | Buy |
|
|||||
|
2019
Q1 | $913K | Buy |
|
|||||
|
2018
Q4 | $573K | Buy |
|
|||||
|
2018
Q3 | $673K | Buy |
|
|||||
|
2018
Q2 | $511K | Buy |
|
|||||
|
2018
Q1 | $313K | Sell |
|
|||||
|
2017
Q4 | $320K | Sell |
|
|||||
|
2017
Q3 | $424K | Buy |
|
|||||
|
2017
Q2 | $470K | Buy |
|
|||||
|
2017
Q1 | $481K | Buy |
|
|||||
|
2016
Q4 | $236K | Buy |
|
|||||
|
2016
Q3 | $204K | Sell |
|
|||||
|
2016
Q2 | $159K | Buy |
|
|||||
|
2016
Q1 | $118K | Buy |
|
|||||
|
2015
Q4 | $315K | Buy |
|
|||||
|
2015
Q3 | $232K | Buy |
|
|||||
|
2015
Q2 | $172K | Buy |
|